LUMIRADX
Live / Registered — Registered (as of 29 Jun 2021)
What this means for you
Registered since 29 Jun 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 13 Jul 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 87445772
- Registration number
- 6403736
- Mark type
- Word mark
- Filed
- 11 May 2017
- Published for opposition
- 27 Feb 2018
- Registered
- 29 Jun 2021
- Next maintenance filing
- §8 declaration of use, filed 13 Jul 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Mona Gupta
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medical diagnostic test strips for use in the detection of chronic diseases, infectious diseases, cardiovascular diseases and conditions, hematology
Owner
- LumiraDx International Ltd, London, GB
- LumiraDx International Ltd, London, GB
- LumiraDx International Ltd, London, GB
Prosecution history
- 13 Jul 2026 — TEAS SECTION 8 & 15 RECEIVED
- 29 Jun 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Sept 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 13 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Sept 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Aug 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 29 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 25 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 May 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Apr 2021 — USE AMENDMENT FILED
- 03 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Apr 2021 — TEAS STATEMENT OF USE RECEIVED